ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      68,210.26
      0.44%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aquinox Pharmaceuticals Inc (AQXP)

      7. Aquinox Pharmaceuticals Inc (AQXP) Financials

      Aquinox Pharmaceuticals Inc

      Aquinox Pharmaceuticals Inc (AQXP)

      NASDAQ
      3.68
      0.00
      (0.00%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Aquinox Pharmaceuticals Inc Financial Summary

      The current AQXP market cap is 42.92M. The company's latest EPS is USD -3.1139 and P/E is -1.12.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -15.14M-3.07M-5.57M-31.82M-18.78M
      Net Income -14.2M-2.09M-4.53M-15.5M-16.92M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 07.83M000
      Operating Income -70.96M-33.73M-60.7M-59.1M-55.58M
      Net Income -69.44M-33.28M-60.69M-57.56M-36.32M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 98.46M94.01M89.59M222.57M195.35M
      Total Liabilities 17.1M14.43M14.35M36.55M24.57M
      Total Equity 81.36M79.58M75.24M186.02M170.78M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 147.02M210.52M163.26M115.95M222.57M
      Total Liabilities 5.34M19.3M20.4M21.62M36.55M
      Total Equity 141.69M191.22M142.86M94.33M186.02M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -13.03M-17.08M-21.35M-51.42M-21.65M
      Investing 10.71M10.3M8.68M25.64M29.94M
      Financing -66k-360k-361k92.48M-6.52M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -15.39M-24.58M-47.56M-45.61M-51.42M
      Investing -688k-2.22M-3.26M-59.13M25.64M
      Financing 82.24M77.14M732k161k92.48M

      Stats and Ratios

      Market Cap 42.92M
      Price to Earnings Ratio -1.12
      Price to Sales Ratio 0
      Price to Cash Ratio 0.27
      Price to Book Ratio 0.22
      Dividend Yield -

      Share Statistics

      Shares Outstanding 11.66M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.45 (11.84%)

      Company Info

      Company Name Aquinox Pharmaceuticals Inc
      Address corporation trust center 1209 orange st
      wilmington, delaware 19802
      Website https://www.neoleukin.com
      Industry pharmaceutical preparations (2834)